您好,欢迎来到上海士研管理咨询有限公司
士研峰会 士研智库 士研调研
嘉宾信息
发布时间: 2019 - 03 - 11
点击次数: 0
所属职位: 总裁兼首席科学官
所属公司: Akshaya Bio Inc.
个人简介:
Dr. Rajan George is the Founder, President and Chief Scientific Officer of Akshaya Bio Inc., a biotechnology company developing vaccines as well as other biotherapeutic agents.Previously, Dr. George was Executive Vice President and Chief Technology Officer of Paladin Biosciences, a division of Paladin Labs Inc. (TSX:PLB), Edmonton, Alberta, Canada. He holds Adjunct Faculty appointment in the Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada. The focus is on the development of therapeutic vaccines for chronic viral infections such as Hepatitis B and Hepatitis C.Dr. George is the co-inventor of Chimigen® Vaccine Platform technology which received the Alberta Science and Technology award for innovation in 2004. He was the recipient of a Grand Challenges Explorations grant from the Bill & Melinda Gates Foundation in 2009. Dr. George was Senior Vice President of Research and Development and a founding member of ViRexx Medical Corp., (TSX:VIR, AMEX:REX), Edmonton, Alberta, Canada, before Paladin acquisition.Previously, a Research Scientist at the Glaxo Heritage Research Institute, University of Alberta, Edmonton, Canada, where the field of research was Hepatitis B virology and antiviral therapy. Dr. George received a Ph.D in Biochemistry from the Indian Institute of Sciences (Bangalore, India). He also had postdoctoral training at the University of Wisconsin in Madison, WI, USA and the University of Alberta (Edmonton, Alberta, Canada).
发布时间: 2019 - 03 - 11
点击次数: 0
所属职位: 总经理兼首席科学家 / 副总裁
所属公司: 北京民海生物科技有限公司 / 深圳康泰生物制品股份有限公司
个人简介:
郑海发,男,研究员,深圳康泰生物制品股份有限公司副总裁,北京民海生物科技有限公司总经理、首席科学家。国家第十一届药典委员会委员;重大新药创制专项、重大传染病专项评审专家;新型疫苗研制技术国家重点实验室主任;中华预防医学会生物制品分会委员;中华医学会微生物与免疫学分会委员;中国医药生物技术协会疫苗专业委员会委员;中国药学会生物药品与质量专业委员;中国药品监督管理研究会生物制品监督管理研究专业委员会委员;中科院过程所硕士导师。
发布时间: 2019 - 03 - 11
点击次数: 0
所属职位: 创始人兼CEO
所属公司: 武汉博沃生物科技有限公司
个人简介:
Dr. Wu Ke is the Founder and CEO of BravoVax. He has more than 30 years of experiences in biopharm industry and had successfully developed 7 products beingapproved by CFDA and marketed in China. He also has 30+ applications/granted patents from China or PCT.He was Executive President of Shanghai Zerun Biotechnology, in charge of management of QA/QC, Manufacture, R&D, Engineering and Maintenance, Regulatory Affairs, Marketing, also extensively experienced in business development, technology transfer, etc. Prior to start Zerun, he was Director of R&D in Wuhan Institute of Biological Products, China National Biotec Group (CNBG), in charge of development of new vaccines and blood products.He holds a PhD degree in Immunology, also alumnus of both China Europe International Business School (CEIBS) and Cheung Kong Graduate School of Business (CKGSB). He is a Guest Professor in several universities.
发布时间: 2019 - 03 - 11
点击次数: 0
所属职位: CEO / CSO
所属公司: BIRD-C G-C GmbH & Co KG
个人简介:
Werner Lubitz , born in Wels, Austria, holds an MSc and a PhD in Microbiology from the Technical University of Munich, Germany. He obtained his postdoctoral training in Cell- and Tumor-Biology at the Institute of Cell Biology, University of Munich, Germany, at the Centre Hopitalier Universitaire Vaudois (CHUV) Lausanne, Switzerland, at the Wallenberg Laboratories, University of Uppsala, Sweden, at the Biocenter, University of Basel, Switzerland, and at the Max Plank Institute of Neurobiology, Martinsried, Germany, and in Genetic Engineering and Microbiology at the Institute of Microbiology, University of Victoria, Canada. Werner Lubitz was Associate Professor of Microbiology at the Institute of Microbiology, University of Kaiserslautern, Germany, and Associate Professor at the Institute of Genetics, University of Munich, Germany. Since 1987, he was Full Professor of Microbiology and Biotechnology at the University of Vienna, Austria, first at the Department of Microbiology, Genetics and Immunology, later at the Department of Medicinal Chemistry, University of Vienna, and the Center of Molecular Biology, Vienna Biocenter. He published more than 200 peer reviewed papers and holds an extensive patent portfolio. Werner Lubitz is the inventor of the Bacterial Ghost Platform Technology He is the founder and cofounder of three Biotech Companies and after retirement from the University of Vienna, 2010, he is the CEO of BIRD-C.
微信公众号
领导者网络APP
友情链接
Copyright ©2005 - 2017上海士研管理咨询有限公司
犀牛云提供企业云服务